82 FR 22550 - Solicitation of Nominations for Appointment to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
DEPARTMENT OF HEALTH AND HUMAN SERVICES Federal Register Volume 82, Issue 93 (May 16, 2017)
Federal Register Volume 82, Issue 93 (May 16, 2017)
| Page Range | 22550-22551 | |
| FR Document | 2017-09778 |
[Federal Register Volume 82, Number 93 (Tuesday, May 16, 2017)] [Notices] [Pages 22550-22551] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-09778] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Solicitation of Nominations for Appointment to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria AGENCY: Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The U.S. Department of Health and Human Services (HHS) is soliciting nominations of individuals who are interested in being considered for appointment to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (Advisory Council) as a non- voting liaison representative member from an organization and/or interest group. Nominations from qualified individuals who wish to be considered for appointment to this member category of the Advisory Council are currently being accepted. DATES: Nominations must be received no later than 5:00 p.m. ET on June 30, 2017. ADDRESSES: Information on how to submit a nomination is on the Advisory Council Web site, http://www.hhs.gov/ash/carb/. FOR FURTHER INFORMATION CONTACT: MacKenzie Robertson, Committee Management Officer, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, Room 715H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690-5566; email: [email protected]. The Advisory Council charter may be accessed online at http://www.hhs.gov/ash/carb/. The charter includes detailed information about the Advisory Council's purpose, function, and structure. SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 18, 2014, authority was given to the Secretary of HHS to establish the Advisory Council, in consultation with the Secretaries of Defense and Agriculture. Activities of the Advisory Council are governed by the provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets forth standards for the formation and use of federal advisory committees. The Advisory Council will provide advice, information, and recommendations to the Secretary of HHS regarding programs and policies intended to preserve the effectiveness of antibiotics by optimizing their use; advance research to develop improved methods for combating antibiotic resistance and conducting antibiotic stewardship; strengthen surveillance of antibiotic-resistant bacterial infections; prevent the transmission of antibiotic-resistant bacterial infections; advance the development of rapid point-of-care and agricultural diagnostics; further research on new treatments for bacterial infections; develop alternatives to antibiotics for agricultural purposes; maximize the dissemination of up-to-date information on the appropriate and proper use of antibiotics to the general public and human and animal healthcare providers; and improve international coordination of efforts to combat antibiotic resistance. The Advisory Council is authorized to consist of not more than 30 members, including the voting and non-voting members and the Chair and Vice Chair. The current composition of the Advisory Council consists of 15 voting members, including the Chair and Vice Chair, five non-voting liaison representative members, and 10 non-voting ex-officio members. The non-voting liaison representatives are selected from organizations and/or interest groups that have involvement in the development, testing, licensing, production, procurement, distribution, and/or use of antibiotics and/or antibiotic research. Organizations are invited to participate as non-voting liaison representatives as it is deemed necessary by the Secretary or designee to accomplish the established mission of the Advisory Council. This announcement is to solicit nominations to fill positions that are scheduled to be vacated during the 2017 calendar year in the non- voting liaison representative member category. Non-voting liaison representative members are appointed to serve two-year terms. Individuals from the following sectors are being sought to serve a non- voting liaison representatives: (1) Professional organizations representing infectious disease, epidemiology, infection control, physicians, nurses, pharmacists, microbiologists, and veterinarians; (2) public health organizations representing laboratories, health officials, epidemiologists (state/territorial, county, or local); (3) organizations advocating for patients and consumers; (4) organizations representing state departments of agriculture; (5) hospitals; (6) foundations with an interest in antibiotic resistance and promoting antibiotic stewardship; (7) pharmaceutical industry--animal and [[Page 22551]] human health; (8) food producers--livestock, poultry, and seafood; (9) in vitro diagnostics; (10) food retailers; (11) food processors; (12) animal feed producers; and (13) farm bio-security. Individuals who are appointed to serve as non-voting liaison representative members may be allowed to receive per diem and reimbursement for any applicable expenses for travel that is performed to attend meetings of the Advisory Council in accordance with federal travel regulations. The Advisory Council meets, at a minimum, two times per fiscal year depending on the availability of funds. Meetings are open to the public, except as determined otherwise by the Secretary or other official to whom the authority has been delegated in accordance with guidelines under the Government in the Sunshine Act, 5 U.S.C. 552b(c). Nominations, including self-nominations, of individuals who represent organizations that have the specified expertise and knowledge sought will be considered for appointment as non-voting liaison representative members of the Advisory Council. Every effort will be made to ensure that the Advisory Council is a diverse group of individuals with representation from various geographic locations, racial and ethnic minorities, all genders, and persons living with disabilities. Detailed information on what is required in a nomination package and how to submit one is on the Advisory Council Web site, http://www.hhs.gov/ash/carb/. Dated: April 25, 2017. Jewel Mullen, Acting Director, National Vaccine Program Office. [FR Doc. 2017-09778 Filed 5-15-17; 8:45 am] BILLING CODE 4150-28-P
![22550 Federal Register / Vol. 82, No. 93 / Tuesday, May 16, 2017 / Notices
competence of testing and calibration DEPARTMENT OF HEALTH AND programs and policies intended to
laboratories) or ISO 15189:2012— HUMAN SERVICES preserve the effectiveness of antibiotics
Medical laboratories—Requirements for by optimizing their use; advance
quality and competence plus FDA Solicitation of Nominations for research to develop improved methods
ASCA program specific requirements? Appointment to the Presidential for combating antibiotic resistance and
FDA would still retain the authority to Advisory Council on Combating conducting antibiotic stewardship;
recognize, deny, amend, or revoke Antibiotic-Resistant Bacteria strengthen surveillance of antibiotic-
recognition of testing laboratories and resistant bacterial infections; prevent
AGENCY: Office of the Assistant the transmission of antibiotic-resistant
maintain the official list of recognized Secretary for Health, Office of the bacterial infections; advance the
testing laboratories. Secretary, Department of Health and development of rapid point-of-care and
4. Where no appropriate accreditation Human Services. agricultural diagnostics; further research
bodies step forward to serve the needs ACTION: Notice. on new treatments for bacterial
for the specific areas within the ASCA infections; develop alternatives to
program, FDA is considering a model SUMMARY: The U.S. Department of
antibiotics for agricultural purposes;
under which it will serve as the Health and Human Services (HHS) is maximize the dissemination of up-to-
soliciting nominations of individuals date information on the appropriate and
accreditation body. What are the
who are interested in being considered proper use of antibiotics to the general
benefits, weaknesses, incentives/
for appointment to the Presidential public and human and animal
disincentives associated with this Advisory Council on Combating
approach, and how do you compare this healthcare providers; and improve
Antibiotic-Resistant Bacteria (Advisory international coordination of efforts to
approach to the private sector approach? Council) as a non-voting liaison combat antibiotic resistance.
5. Describe your familiarity with representative member from an The Advisory Council is authorized to
accreditation to ISO/IEC 17025 (General organization and/or interest group. consist of not more than 30 members,
requirements for testing and calibration Nominations from qualified individuals including the voting and non-voting
laboratories) or ISO 15189:2012— who wish to be considered for members and the Chair and Vice Chair.
Medical laboratories—Requirements for appointment to this member category of The current composition of the
quality and competence? If accredited, the Advisory Council are currently Advisory Council consists of 15 voting
what is the scope of accreditation? being accepted. members, including the Chair and Vice
6. Do you utilize another management DATES: Nominations must be received Chair, five non-voting liaison
system other than ISO/IEC 17025 or ISO no later than 5:00 p.m. ET on June 30, representative members, and 10 non-
15189:2012—Medical laboratories— 2017. voting ex-officio members. The non-
Requirements for quality and ADDRESSES: Information on how to voting liaison representatives are
submit a nomination is on the Advisory selected from organizations and/or
competence? If so, what management
Council Web site, http://www.hhs.gov/ interest groups that have involvement in
system has been implemented? the development, testing, licensing,
ash/carb/.
7. Are there specific FDA recognized production, procurement, distribution,
FOR FURTHER INFORMATION CONTACT:
consensus standards available at http:// and/or use of antibiotics and/or
MacKenzie Robertson, Committee
www.accessdata.fda.gov/scripts/cdrh/ antibiotic research. Organizations are
Management Officer, Presidential
cfdocs/cfStandards/search.cfm or invited to participate as non-voting
Advisory Council on Combating
testing capabilities related to the liaison representatives as it is deemed
Antibiotic-Resistant Bacteria, Office of
medical devices sector that you necessary by the Secretary or designee
the Assistant Secretary for Health, U.S.
perform? to accomplish the established mission of
Department of Health and Human
the Advisory Council.
8. For more complex standards, such Services, Room 715H, Hubert H. This announcement is to solicit
as those that have normative references Humphrey Building, 200 Independence nominations to fill positions that are
or include references to management Avenue SW., Washington, DC 20201. scheduled to be vacated during the 2017
systems (e.g., Risk Management, Quality Phone: (202) 690–5566; email: CARB@ calendar year in the non-voting liaison
Management, Cybersecurity, Infection hhs.gov. The Advisory Council charter representative member category. Non-
Control), are there specific assessment may be accessed online at http:// voting liaison representative members
techniques that should be included? www.hhs.gov/ash/carb/. The charter are appointed to serve two-year terms.
includes detailed information about the Individuals from the following sectors
9. Would you consider participating Advisory Council’s purpose, function,
in the ASCA Pilot Program? If so, what are being sought to serve a non-voting
and structure. liaison representatives: (1) Professional
scope of testing would you consider?
SUPPLEMENTARY INFORMATION: Under organizations representing infectious
10. Generally, are there any other Executive Order 13676, dated disease, epidemiology, infection control,
comments that you would like to September 18, 2014, authority was given physicians, nurses, pharmacists,
provide regarding the development of to the Secretary of HHS to establish the microbiologists, and veterinarians; (2)
the ASCA pilot program? Do you have Advisory Council, in consultation with public health organizations representing
recommendations for other alternatives the Secretaries of Defense and laboratories, health officials,
to consider? Agriculture. Activities of the Advisory epidemiologists (state/territorial,
Council are governed by the provisions
sradovich on DSK3GMQ082PROD with NOTICES
Dated: May 10, 2017. county, or local); (3) organizations
of Public Law 92–463, as amended (5 advocating for patients and consumers;
Anna K. Abram,
U.S.C. App.), which sets forth standards (4) organizations representing state
Deputy Commissioner for Policy, Planning, for the formation and use of federal departments of agriculture; (5) hospitals;
Legislation, and Analysis. advisory committees. The Advisory (6) foundations with an interest in
[FR Doc. 2017–09850 Filed 5–15–17; 8:45 am] Council will provide advice, antibiotic resistance and promoting
BILLING CODE 4164–01–P information, and recommendations to antibiotic stewardship; (7)
the Secretary of HHS regarding pharmaceutical industry—animal and
VerDate Sep<11>2014 16:42 May 15, 2017 Jkt 241001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 E:\FR\FM\16MYN1.SGM 16MYN1](https://thefederalregister.org/doc/82_FR_22643/page/1.svg)
![Federal Register / Vol. 82, No. 93 / Tuesday, May 16, 2017 / Notices 22551
human health; (8) food producers— comment. Any individual who wishes contact at least seven (7) business days
livestock, poultry, and seafood; (9) in to participate in the call should email prior to the meeting.
vitro diagnostics; (10) food retailers; (11) OMH-ACMH@hhs.gov by May 30, 2017. Any members of the public who wish
food processors; (12) animal feed Instructions regarding participating in to have electronic or printed material
producers; and (13) farm bio-security. the call and how to provide verbal distributed to ACMH members should
Individuals who are appointed to public comments will be given at the email OMH-ACMH@hhs.gov or mail
serve as non-voting liaison time of preregistration. their materials to the Designated Federal
representative members may be allowed Information about the meeting is Officer, ACMH, Tower Building, 1101
to receive per diem and reimbursement available from the designated contact Wootton Parkway, Suite 600, Rockville,
for any applicable expenses for travel and will be posted on the Web site for Maryland 20852, prior to close of
that is performed to attend meetings of the Office of Minority Health (OMH), business on May 25, 2017.
the Advisory Council in accordance www.minorityhealth.hhs.gov. Dated: May 11, 2017.
with federal travel regulations. The Information about ACMH activities can Minh Wendt,
Advisory Council meets, at a minimum, be found on the OMH Web site under Designated Federal Officer, Advisory
two times per fiscal year depending on the heading About OMH. Committee on Minority Health.
the availability of funds. Meetings are DATES: The conference call will be held [FR Doc. 2017–09862 Filed 5–15–17; 8:45 am]
open to the public, except as on June 1, 2017, 12:30 p.m.–2:30 p.m. BILLING CODE 4150–29–P
determined otherwise by the Secretary ET.
or other official to whom the authority
has been delegated in accordance with ADDRESSES: Instructions regarding
participating in the call will be given at DEPARTMENT OF HEALTH AND
guidelines under the Government in the
the time of preregistration. HUMAN SERVICES
Sunshine Act, 5 U.S.C. 552b(c).
Nominations, including self- FOR FURTHER INFORMATION CONTACT: Dr. National Institutes of Health
nominations, of individuals who Minh Wendt, Designated Federal
represent organizations that have the Officer, Advisory Committee on Solicitation of Public Comments on the
specified expertise and knowledge Minority Health, Office of Minority Draft Federal Pain Research Strategy
sought will be considered for Health, Department of Health and
appointment as non-voting liaison Human Services, Tower Building, 1101 National Institute of Neurological
representative members of the Advisory Wootton Parkway, Suite 600, Rockville, Disorders and Stroke, Interagency Pain
Council. Every effort will be made to Maryland 20852. Phone: 240–453–8222; Research Coordinating Committee
ensure that the Advisory Council is a fax: 240–453–8223; email OMH-ACMH@ Solicitation for Public Comments on the
diverse group of individuals with hhs.gov. Draft Federal Pain Research Strategy
representation from various geographic Pursuant to section 10(a) of the
SUPPLEMENTARY INFORMATION: In Federal Advisory Committee Act, as
locations, racial and ethnic minorities, accordance with Public Law 105–392,
all genders, and persons living with amended (5 U.S.C. App), notice is
the ACMH was established to provide hereby given of a meeting hosted by the
disabilities. Detailed information on advice to the Deputy Assistant Secretary
what is required in a nomination National Institutes of Health to present
for Minority Health on improving the the Draft Federal Pain Research Strategy
package and how to submit one is on health of each racial and ethnic
the Advisory Council Web site, http:// and to solicit public comments on this
minority group and on the development document. The meeting will be open to
www.hhs.gov/ash/carb/. of goals and specific program activities the public and videocast.
Dated: April 25, 2017. of the OMH. Dates: June 1, 2017.
Jewel Mullen, The topics to be discussed during the Time: 12:45 p.m. to 3:30 p.m.
Acting Director, National Vaccine Program teleconference include creating a work *Eastern Time*.
Office. plan for developing recommendations Agenda: Invited speakers will present
[FR Doc. 2017–09778 Filed 5–15–17; 8:45 am] related to opioid usage and health and discuss research recommendations
BILLING CODE 4150–28–P disparities. The recommendations will developed for the Draft Federal Pain
be given to the Deputy Assistant Research Strategy. Attendees will have
Secretary for Minority Health. the opportunity to pose questions on
DEPARTMENT OF HEALTH AND This call will be limited to 125 site or on-line. Information to submit
HUMAN SERVICES participants. The OMH will make every comments in advance and during the
effort to accommodate persons with meeting will be posted on May 25th,
Meeting of the Advisory Committee on special needs. Individuals who have 2017, at https://iprcc.nih.gov/.
Minority Health special needs for which special Summary: The Federal Pain Research
AGENCY: Office of Minority Health, accommodations may be required Strategy is an effort of the Interagency
Office of the Secretary, Department of should contact Professional and Pain Research Coordinating Committee
Health and Human Services. Scientific Associates at (703) 234–1700 (IPRCC) and the NINDS Office of Pain
ACTION: Notice of meeting.
and reference this meeting. Requests for Policy to oversee development of a long-
special accommodations should be term strategic plan for pain research. A
SUMMARY: As stipulated by the Federal made at least ten (10) business days diverse and balanced group of scientific
Advisory Committee Act, the prior to the meeting. experts, patient advocates, and federal
Department of Health and Human Members of the public will have an representatives identified and
sradovich on DSK3GMQ082PROD with NOTICES
Services (HHS) is hereby giving notice opportunity to provide comments at the prioritized research recommendations
that the Advisory Committee on meeting. Public comments will be as a basis for a long-term strategic plan
Minority Health (ACMH) will hold a limited to two minutes per speaker to coordinate and advance the federal
meeting conducted as a telephone during the time allotted. Individuals research agenda. The key areas of
conference call. This call will be open who would like to submit written prevention of acute and chronic pain,
to the public. Preregistration is required statements should email, mail, or fax acute pain and acute pain management,
for both public participation and their comments to the designated the transition from acute to chronic
VerDate Sep<11>2014 16:42 May 15, 2017 Jkt 241001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\16MYN1.SGM 16MYN1](https://thefederalregister.org/doc/82_FR_22643/page/2.svg)
Document Created: 2017-05-16 13:52:31
Document Modified: 2017-05-16 13:52:31
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | Nominations must be received no later than 5:00 p.m. ET on June 30, 2017. | |
| Contact | MacKenzie Robertson, Committee Management Officer, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, Room 715H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690-5566; email: [email protected] The Advisory Council charter may be accessed online at http://www.hhs.gov/ash/carb/. The charter includes detailed information about the Advisory Council's purpose, function, and structure. | |
| FR Citation | 82 FR 22550 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR